R. Weinmann

发表

Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus.

J. Hunt, Donna D Wei, M. Salvati, 2005, Bioorganic & medicinal chemistry letters.

Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists.

K. Kish, S. Krystek, Donna D Wei, 2005, Bioorganic & medicinal chemistry letters.

The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists.

J. Tokarski, A. Mathur, L. Leith, 2004, Bioorganic & medicinal chemistry letters.

Stable Transfection of Human Malignant Melanoma Cells with Basic Fibroblast Growth Factor Antisense cDNA a

M. Herlyn, U. Rodeck, R. Weinmann, 1992, Annals of the New York Academy of Sciences.

Transforming region of 243R E1A contains two overlapping but distinct transactivation domains.

A. Giordano, Y. Fu, P. Claudio, 1997, DNA and cell biology.

Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus.

J. Hunt, M. Salvati, A. Balog, 2005, Bioorganic & medicinal chemistry letters.

Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.

M. Barbacid, C. Der, B. Seizinger, 1995, Oncogene.

inhibitors stem and progenitor cells and synergizes with tyrosine kinase BMS-214662 potently induces apoptosis of chronic myeloid leukemia

M. Copland, A. Hamilton, T. Holyoake, 2013 .

BMS-214662 potently induces apoptosis of Chronic Myeloid Leukemia stem and progenitor cells and synergises with tyrosine kinas

M. Copland, F. Lee, A. Hamilton, 2007 .

Identification of novel functional inhibitors of 17β‐hydroxysteroid dehydrogenase type III (17β‐HSD3)

I. Takenaka, B. Fink, M. Salvati, 2005 .

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

Howard M. Einspahr, Stanley R. Krystek, K. Kish, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.

Paul S Mischel, Timothy F Cloughesy, Joseph A Loo, 2009, Cancer research.

Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes

G. Trinchieri, B. Perussia, M. Cuturi, 1987, The Journal of experimental medicine.

Fyn and Src are Effectors of Oncogenic EGFR Signaling in Glioblastoma Patients

J. Caldwell, S. Nelson, C. James, 2009 .

Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3).

I. Takenaka, B. Fink, M. Salvati, 2005, The Prostate.

Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice

F. Lee, Yiguo Hu, Shaoguang Li, 2006, Proceedings of the National Academy of Sciences.

BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors.

M. Copland, F. Lee, A. Hamilton, 2008, Blood.

Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists.

K. Kish, S. Krystek, M. Salvati, 2005, Bioorganic & medicinal chemistry letters.

Targeting BCR-ABL Kinase Activity-Independent Signaling Pathways and Leukemia Stem Cells Is Essential for Curative Therapy of Philadelphia Chromosome Positive (Ph+) Leukemia.

F. Lee, Yiguo Hu, Shaoguang Li, 2005 .

Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.

M. Barbacid, C. Der, B. Seizinger, 1995, Oncogene.

BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors.

M. Copland, A. Hamilton, T. Holyoake, 2008, Blood.